Evaluation of left ventricular systolic function in opium users by strain echocardiography. [PDF]
Mohammadi K+5 more
europepmc +1 more source
The value of myocardial work in the estimation of left ventricular systolic function in patients with coronary microvascular disease: A study based on adenosine stress echocardiography. [PDF]
Liu Q+7 more
europepmc +1 more source
Abstract Aims Functional tricuspid regurgitation (FTR) associated with degenerative mitral regurgitation (DMR) accentuates the severity of heart failure and is a marker of poor prognosis. Little is known about FTR associated with asymptomatic DMR. Methods and results The study included 1249 asymptomatic patients with moderate or severe DMR from the ...
Christophe Tribouilloy+16 more
wiley +1 more source
NT-proBNP: a new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function [PDF]
M. Bay
openalex +1 more source
Right Ventricular Systolic Dysfunction Predicts Recovery of Left Ventricular Systolic Function and Reduced Quality of Life in Patients With Arrhythmia-Induced Cardiomyopathy. [PDF]
Körtl T+9 more
europepmc +1 more source
Quantitative Echocardiography Improves Resident Assessment of Left Ventricular Systolic Function. [PDF]
Wu AH+7 more
europepmc +1 more source
In NIDCM patients, native T1 mapping and ECV were associated with increased risk of the composite primary endpoint of MACE and the secondary endpoint of heart failure and arrhythmic‐related events. Patients who experienced MACE had higher values of both T1 mapping and ECV.
Federico Marchini+9 more
wiley +1 more source
Left ventricular systolic function after inhalation of beta-2 agonists in healthy athletes. [PDF]
Persch H+10 more
europepmc +1 more source
Immune Checkpoint Inhibitors and Cardiovascular Adverse Events
Abstract In the last years, we assisted to a tremendous increase in therapeutic options for the management of cancers, with immunotherapy at the forefront of this innovation. Immune checkpoint inhibitors (ICIs) have been developed to enhance the activity of the immune system against cancer cells (1) and the number of approvals for ICIs has rapidly ...
Maria Luisa De Perna+4 more
wiley +1 more source